YCM
HZNP

Yousif Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Yousif Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,752
Closed -$318K – 2015
2023
Q3 		$318K Buy
2,752
+155
+6% +$16.7K ﹤0.01% 1684
2023
Q2 		$267K Sell
2,597
-100
-4% -$10.6K ﹤0.01% 1757
2023
Q1 		$294K Buy
2,697
+45
+2% +$4.97K ﹤0.01% 1709
2022
Q4 		$302K Buy
+2,652
New +$220K ﹤0.01% 1710
2022
Q3 		– Sell
-2,549
Closed -$203K – 2000
2022
Q2 		$203K Sell
2,549
-840
-25% -$79.5K ﹤0.01% 1838
2022
Q1 		$357K Buy
3,389
+105
+3% +$10.2K ﹤0.01% 1755
2021
Q4 		$354K Buy
+3,284
New +$358K ﹤0.01% 1772

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Yousif Capital Management's HZNP Position: Q4 2023 in Review

Yousif Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,752 shares — an estimated $318K sold.

Yousif Capital Management first reported a position in HZNP in Q4 2021 and held it in 7 quarters. The position peaked at $357K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Yousif Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Yousif Capital Management sold 2,752 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $318K.
  • Yousif Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 7 quarters.
  • Yousif Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $357K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Yousif Capital Management's 13F filing for Q4 2023, filed 1 Feb 2024.